PBS LISTED FOR COPD & SEVERE ASTHMA 1
PBS
LISTED FOR COPD 1
NEW HIGH STRENGTH PBS LISTED FOR SEVERE
ASTHMA 1
Extrafine * Trimbow is the only 3-in-1 pMDI indicated for adult COPD † and asthma 2 ‡
* Mass median aerodynamic diameter particle size < 2 μm . 2
‡
Trimbow 200 is indicated for the maintenance treatment of asthma , in adults not adequately controlled with a maintenance combination of a high dose of ICS / LABA , and who experienced ≥1 exacerbations in the previous year . 2
† Trimbow 100 is indicated for the maintenance treatment of patients with moderate to severe COPD who are not adequately treated by a combination of an ICS + LABA or a LABA + LAMA . 2
Visit chiesi . com . au to learn more
Please review Product Information before prescribing . Product Information is available by scanning the QR code .
PBS Information : Authority required ( STREAMLINED ). Severe Asthma ( 200 / 6 / 10 mcg presentation only ). Chronic Obstructive Pulmonary Disease ( 100 / 6 / 10 mcg presentation only ). Criteria Apply . Refer to PBS Schedule for full information .
Abbreviations : COPD , chronic obstructive pulmonary disease ; ICS , inhaled corticosteroid ; LABA , long-acting beta 2-agonist ; LAMA , long-acting muscarinic antagonist ; PBS , Pharmaceutical Benefits Scheme ; pMDI , pressurised metered dose inhaler . References : 1 . Pharmaceutical Benefits Scheme ( PBS ). Available at : https :// www . pbs . gov . au . 2 . Approved Trimbow Product Information . Chiesi Australia Pty Ltd , Suite 3 , 22 Gillman Street , Hawthorn East , VIC . 3123 , Australia . Tel : + 61 3 9077 4486 ; Fax : + 61 3 8672 0792 ; Email : medicalaffairs . au @ chiesi . com ; Website : www . chiesi . com . au . Copyright © Chiesi 2022 . All rights reserved . Date of preparation : January 2023 . AU-TRI-2200115 . CHIE00042i .